Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Teratoma 1Glioma 1Choriocarcinoma 1Carcinoma, Embryonal 1Astrocytoma 1

Interventions

Etoposide 18Cisplatin 16Ifosfamide 14Carboplatin 14Filgrastim 12Bleomycin 12Peripheral Blood Stem Cell Transplantation 9Paclitaxel 9Radiotherapy 6etoposide phosphate 5Thiotepa 5Granulocyte Colony-Stimulating Factor 5Cyclophosphamide 4pegfilgrastim 3Mesna 3Magnetic Resonance Spectroscopy 3liposomal amphotericin B 2ixabepilone 2Vinblastine 2Therapeutics 2Temozolomide 2Specimen Handling 2Psychiatric Rehabilitation 2Oxaliplatin 2Neoadjuvant Therapy 2Immunohistochemistry 2Chemotherapy, Adjuvant 2Amifostine 2sodium thiosulfate 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Teratoma × Reoperation × Clear all
NCT04684368 2026-05-05

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Children's Oncology Group

Phase 2 Recruiting
160 enrolled

Choriocarcinoma, Teratoma, Carcinoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡